Ethyl 4,6-dichloronicotinate

Catalog No.: 
ACDRIC265
CAS No.: 
40296-46-6
Molecular Formula: 
C8H7Cl2NO2
Molecular Weight: 
220.05
Ethyl 4,6-dichloronicotinate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$88.00In stockInquiry
500g98%$439.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 4,6-dichloronicotinate
IUPAC Nameethyl 4,6-dichloronicotinate
MDL No.MFCD00234408
Molecular FormulaC8H7Cl2NO2
Molecular Weight220.05
SMILESO=C(OCC)C1=CN=C(Cl)C=C1Cl
InChI KeyAAUBVINEXCCXOK-UHFFFAOYSA-N
SynonymCS-W002558 | ETHYL 4,6-DICHLORO-3-PYRIDINECARBOXYLATE | 4,6-Dichloropyridine-3-carboxylic acid ethyl ester | Ethyl 4,6-dichloronicotinate | Tox21_110438 | FT-0617243 | E1068 | MFCD00234408 | HY-W002558 | Pyridine-3-carboxylic acid, 4,6-dichloro-, ethyl es
CAS No.40296-46-6
PubChem CID600045

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACDRIC265 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRIXJ630 route compound structure diagram
    ACRIXJ6306975-44-6In Stock
  2. Then
  3. ACDRIC265 route product structure diagram
    ACDRIC26540296-46-6In Stock
Inquiry

2. ACDRIC265 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACOKCS685 route compound structure diagram
    ACOKCS68573027-79-9In Stock
  4. Then
  5. ACDRIC265 route product structure diagram
    ACDRIC26540296-46-6In Stock
Inquiry

3. ACDRIC265 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBTJC485 route compound structure diagram
    ACBTJC485105-50-0
  2. Then
  3. ACDRIC265 route product structure diagram
    ACDRIC26540296-46-6In Stock
Inquiry

Comments (0)